Renal Function Test Market Projected to Reach US$ 900 Mn by 2026

According to Future Market Insights (FMI), the global renal function test market is projected to register a steady expansion over the forecast period, 2017 to 2026. Revenues from worldwide use of renal function test are estimated to surpass US$ 900 Mn by 2026-end.

Public & Private Healthcare Organizations are Supporting Management of CKD through Programs & Initiatives

Increasing incidences of renal failure, and chronic kidney diseases (CKD) are considered to be the primary factors responsible for the significant demand for renal function tests. Unhealthy dietary habits, lack of physical exercise owing to hectic lifestyles, and stress, are commonly observed risk factors for diabetes, coronary heart diseases, hypercholesterolemia, and hypertension. These factors further lead toward dysfunctions in the kidney, which in turn creates demand for renal function tests. Surging number of people with diabetes who are highly susceptible to CKD are expected to propel the demand for renal function tests in the upcoming years. The resultant high sample volume is creating demand for highly effective and efficient renal function testing devices.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5845

Awareness about diagnostic benefits related to renal function tests is increasing among people. The advent of technologically advanced products associated with renal function tests such as automated analyzers has resulted into refinement of present point-of-care real-time testing capabilities. In addition, the private as well as public healthcare organizations are consistently striving to support the diagnosis and management of chronic kidney diseases through various programs and initiatives, thereby creating awareness and demand for renal function tests.

Key Takeaways from FMI’s Report on Renal Function Test Market

• North America will continue to be dominant in the global renal function test market, in terms of revenues. Between renal function test market in Europe and Asia-Pacific excluding Japan (APEJ), the former will account for a larger revenue share and the latter will register a relatively higher CAGR through 2026. The renal function test markets in Middle East & Africa (MEA) and Japan are projected to account for the lowest revenue share of the market throughout the forecast period.
• On the basis of product type, dipsticks are expected to be the leading contributor to the market growth, in terms of revenues. Revenues from sales of disposables and reagents are projected to register a relatively faster expansion, and will collectively account for over two-fifth share of the market during the forecast period.
• Hospitals are anticipated to remain the most lucrative end-users in the global renal function test market, with sales estimated to surpass US$ 450 Mn in revenues by 2026-end. Diagnostic laboratories are expected to remain the fast-expanding end-users of renal function tests through 2026. Revenues from renal function tests in diagnostic laboratories are projected to account for nearly one-third share of the market by 2026-end. Research institutes will continue to be the least lucrative end-users of renal function tests.
• In terms of test type, urine protein and microalbumin renal function test are together projected to account for over three-fifth revenue share of the market during the forecast period. Revenues from microalbumin renal function test will register the highest CAGR in the market through 2026. In addition, revenues from urine protein and serum creatinine renal function test are projected to increase at nearly equal CAGRs through 2026.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5845

Vendors in the global renal function test market are focusing on technological advancements through clinical trials. The intensive competitive landscape of the market is resulting into increasing mergers & acquisition activities, wherein smaller firms are acquired by well-established international vendors. Key player profiled by FMI’s report include Randox Laboratories, Elektronika, Acon Laboratories, Urit Medical, Nova Biomedical, Sysmex, Abbott, Roche, Beckman Coulter, and Siemens.

Automated CPR Devices Market is estimated to be worth US$ 191.2 Mn by 2027

Future Market Insights (FMI) announces the release of its latest outlook titled,“Automated CPR Devices Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017–2027)”. According to the report, the global automated CPR devices market was valued at US$ 60.0 Mn in 2016 and is anticipated to reach US$ 191.2 Mn by 2027, registering a compound annual growth rate (CAGR) of 11.3% throughout the 10 year forecast period.

Market Drivers and Restraints

The global automated CPR devices market is largely driven by a growing demand from emergency medical services and a rising need for technologically advanced EMS. An increasing public awareness of cardiac arrest and increasing training programmes is also positively influencing revenue growth of the automated CPR devices market. Also, increasing government funding and grants encouraging the use of automated CPR devices in order to improve survival rates of cardiac arrest victims coupled with a rapidly increasing geriatric population across the globe owing to the impact of reducing mortality rates and declining fertility rates has also widened the scope for automated CPR device manufacturers.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5343 

Conversely, high cost of automated CPR devices, the substantial weight of the device and high training requirements are some minor restraints in the global automated CPR devices market. Additionally, conflicting results from observational studies regarding the use of automated CPR devices is also hampering the growth of the automated CPR devices market. While some observational studies have confirmed that the application of automated CPR devices can immediately improve hemodynamic effect and perfusion, some studies show less or no impact from the use of such devices.

Unmet clinical needs are expected to offer favourable growth opportunities in the near future. Increasing demand for innovative products so as to ensure cardiac arrest survival rates through cardiopulmonary resuscitation are providing favourable prospects for growth of the global automated CPR devices market. There is a strong need for the improvement of existing CPR devices with some desired features such as inbuilt pulse rate check function and automated injectable function.

Global Automated CPR Devices Market: Forecast by End User

Among the various end users of automated CPR devices, the hospitals segment is likely to dominate throughout the forecast period with a CAGR of 11.6% in terms of value.The emergency medical services segment remains the third largest market and represents a Market Share Index of 0.6 over the forecast period.

Global Automated CPR Devices Market: Forecast by Region

Region-wise, Europe dominated the global automated CPR devices market in 2016 in terms of revenue, accounting for 36.5% revenue share. However, Asia Pacific is foreseen to witness a relatively high CAGR of 11.1%. The market in Europe is expected to remain dominant throughout the forecast period.

Adoption rates for automated CPR devices vary according to region, which is resulting in disparity in market trends across regions. Factors such as differentiation in EMS and its functioning and lack of awareness amongst the populace are responsible for the varying adoption rates across different geographies. The U.S. is witnessing major investments in automated CPR devices due to the increasing number of market players with new technologies in the region.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5343 

Global Automated CPR Devices Market: Competitive Landscape

Key players considered in the global automated CPR devices market include ZOLL Medical Corporation, Physio-Control Inc., Brunswick Biomedical Technologies, Michigan Instruments, and SunLife Science Inc. The global automated CPR devices market is consolidated with the top two players bagging over 50% of the total market share. Most players are engaged in various activities such as new product development, increasing investments in clinical research, expansion of geographical presence and brand building via strong marketing strategies in order to sustain in the competitive global market.

Clinical Alarm Management Market is Expected to Generate Huge Profits by 2027

Clinical alarm management solutions are adopted by hospitals and ambulatory surgical centres to manage and respond to clinical alarms as and when they arise to minimize alarm fatigue. Clinical alarm management solutions are implemented by several enterprises for a number of applications and include clinical decision support tools, mobility solutions, central monitoring systems, alarm auditing software, and clinical alarm reporting software. In its recent report titled, ‘Clinical Alarm Management Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’, Future Market Insights has conducted a thorough analysis of the global clinical alarm management market. The clinical alarm management market is anticipated to push past a value of US$ 4 billion by end 2027.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1713 

Component – Solutions Component Dominate Clinical Alarm Management Market

The solutions component is projected to be more than thrice the size of the services component at the end of the forecast period and key stakeholders in the clinical alarm management market are advised to take this into account. The solutions component could exceed a value of US$ 3 billion by the end of the decadal study with a third of this being in the clinical decision support tools sub-segment. However, a substantially higher CAGR is likely in the mobility solutions segment as the number of smartphone users has risen exponentially in the past few years. Most healthcare professionals access their smartphone to monitor their patients on a real-time basis via patient monitoring apps. This enhances caregiver efficiency by minimizing institutional operational cost and allows organizations to use mobility for alarm management as well as clinical decision support.

End User – Focus on Hospitals and Ambulatory Surgical Centres in Clinical Alarm Management Market

Hospitals and ambulatory surgical centres are the largest end-users in the clinical alarm management market and should remain so for the foreseeable future. Although hospitals are approx. thrice the size of ambulatory surgical centres, the latter is on track to post a higher CAGR of 9.5% from 2017 to 2027, making the segment vital for companies involved in the clinical alarm management market. A major challenge faced by hospitals is alarm fatigue that can occur because different clinical alarms generated by medical devices can have a devastating impact on clinicians, patients, and relatives. Alarm fatigue occurs when clinicians are desensitized and non-reactive on account of an overwhelming load and is a grave threat for patient safety. Human factors, staffing issues, and technological also come into play here and all this can significantly hamper growth of the clinical alarm management market.

Region – North America Largest Contributor in Clinical Alarm Management Market

North America had a market share of slightly under half the clinical alarm management market at the end of 2017 but is projected to lose a massive 420 BPS going forward. Nonetheless, its commanding lead ensures that Western Europe doesn’t surpass it during the course of the forecast period. The US accounts for roughly 4/5th of the North America clinical alarm management market because the US Department of Health and Human Services allow reimbursement models such as bundled payments. Medicare and Medicaid service centres are striving to achieve greater cancer care consistency and cost predictability with the adoption of clinical decision tools. These tools play a game-changing role improving safety, quality, and efficiency as they offer timely, relevant information to healthcare professionals at a lower cost.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1713  

Competition Dashboard in Clinical Alarm Management Market

Companies profiled in the clinical alarm management market report are Medtronic, GE Healthcare, Baxter, Koninklijke Philips, Connexall, Vocera, Drager, Mindray Medical International Limited, , and Spok Inc.

Takeaways

Vendors dealing in clinical alarm management software could try to streamline their product portfolio by seamlessly integrating their platform / solutions with local players through a joint venture or strategic partnership. Mobility solution is poised to witness immense growth as smartphone ownership will skyrocket in future. Therefore, investing in mobility solutions could be a wise bet.

Pneumonia Diagnostics Market Progresses for Huge Profits During 2017-2027

The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report titled ‘Pneumonia Diagnostics Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’, Future Market Insights has undertaken a comprehensive study of the pneumonia diagnostics market that is poised to be worth more than US$ 685 million in 2027.

Product Type – Focus on Streptococcus-based and Viral Pneumonia-based Product Types

The streptococcus-based product type is the largest in the pneumonia diagnostics market at the end of 2016 and is unlikely to fall behind anytime soon. The streptococcus-based segment is the only one worth more than US$ 100 million in 2017 alone. Streptococcus-based pneumonia is considered an invasive form of the infection with an incidence of 10 to 100 cases per a population of 100,000.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2970 

The viral pneumonia- based segment is predicted to witness the highest CAGR in the pneumonia diagnostics market over the course of the decade. The viral pneumonia segment of the pneumonia diagnostics market should cross US$ 180 million by end 2027, making it well worth the while of major stakeholders. Viral-based pneumonia is thought to cause approx. 8% of all cases of community-acquired pneumonia in the cases where patients required hospitalization.

Region – North America and Western Europe Vital in Pneumonia Diagnostics Market

North America has the maximum share in the pneumonia diagnostics market and is on track to retain this share for some time. The US, primarily due to its world-class healthcare infrastructure and a geriatric population susceptible to pneumonia, represents a larger opportunity than Canada in the North America pneumonia diagnostics market. In addition to this, there is high awareness about pneumonia and its debilitating effects on both infants and the elderly. The North America pneumonia diagnostics market is expected to just push past US$ 200 million by the end of the forecast period.

Western Europe follows North America in the pneumonia diagnostics market with Germany and the UK comprising the bulk of the regional market. The two behemoths represent more than 40% of the Western Europe pneumonia diagnostics market between themselves and companies are advised to focus their attention there. The Western Europe pneumonia diagnostics market is anticipated to record a robust CAGR of 6.2% from 2017 to 2027, making it a region too lucrative to ignore in the global pneumonia diagnostics market. The market attractiveness of Germany is much higher than that of the UK at 1.6.

Competition Dashboard in the Pneumonia Diagnostics Market

Prominent companies profiled in the pneumonia diagnostics market report include Thermo Fisher Scientific, Alere, Quidel Corporation, Becton Dickinson and Company, Meridian Bioscience, Qiagen N.V., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., and Beckman Coulter Inc.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2970 

Takeaways

Changing global demographics coupled with greater medical awareness increase the potential for companies in the pneumonia diagnostics market. Manufacturers are seeking to introduce rapid diagnostics to exploit untapped opportunities and producers of pneumonia diagnostics have expanded the value chain to forward integrate the market in emerging economies. A high return on investment could be realized by shifting manufacturing from traditional culture techniques to rapid diagnostics at the point of care.

Hyaluronic Acid Products Market Size Projected to Rise Lucratively during 2027

The World Bank estimates that the geriatric population in the world’s most populous country China had reached 10% of the population in 2016. The United Nations believes that nearly a third of the country will be over the age of 60 in 2050. A geriatric population is far more susceptible to osteoporosis the treatment of which necessitates hyaluronic acid products. Future Market Insights in its report titled ‘Hyaluronic Acid Products Market: Global Industry Analysis 2012 –2016 and Opportunity Assessment 2017 – 2027’ anticipates the global hyaluronic acid products market to be worth approx. US$ 5 billion in 2027.

Product Type – Three Cycle Injection Products Critical in Hyaluronic Acid Products Market

The three-cycle injection product segment is the largest in the hyaluronic acid products market at the end of 2017 and is on track to retain its pole position for the next decade. The three cycle injection product segment is predicted to have a value of just under US$ 2 billion by end 2027, making it vital for key stakeholders in the hyaluronic acid products market. The market attractiveness of three cycle injection products is 1.2. However, three cycle injection products typically have a premium price and it remains to be seen if they become as popular in emerging economies as they are in developed ones.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-486 

Application – Osteoarthritis and Dermal Fillers Neck and Neck in Hyaluronic Acid Products Market

There is a close battle between the osteoarthritis and dermal fillers application segment in the hyaluronic acid products market with the former inching slightly ahead. The CAGR of the osteoarthritis segment is 7.8% to the 7.7% witnessed in the dermal fillers segment from 2017 to 2027. Therefore, it wouldn’t be advisable to ignore one of these over the other in the hyaluronic acid products market. There has been a noticeable spike in osteoarthritis patients seeking out alternative options to knee replacement in order to avoid the side effects of corticosteroids injections that could pose a challenge to growth in the hyaluronic acid products market.

Region – Target North America and Western Europe Hyaluronic Acid Products Market

North America and Western Europe hold the maximum share in hyaluronic acid products market and are likely to remain so for some time to come. The two regions are expected to be the only ones in the hyaluronic acid products market worth more than one billion dollars by the end of the forecast period with a higher CAGR in North America. Favourable reimbursement policies for treating various scar conditions fuels demand for hyaluronic acid products in the US. Furthermore, reimbursement for HA injections also play a major role.

Competition Dashboard in the Hyaluronic Acid Products Market

Future Market Insights has profiled a few of the companies in the hyaluronic acid products market. The companies are Allergan plc, Anika Therapeutics, Shanghai Jingfeng Pharmaceutical Co., Ferring Pharmaceuticals, Galderma SA, Sanofi, Salix Pharmaceuticals Ltd., Smith & Nephew, Zimmer Biomet, Seikagaku Corporation, and Fidia Farmaceutici.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-486 

Takeaways

Manufacturers in the hyaluronic acid products market have focused their attention on developing new custom-made implants for minimally invasive surgery. Companies now outsource their manufacturing to reduce the high cost and thereby improve their competitive position vis-à-vis their immediate rivals in hyaluronic acid products market. Lastly, companies have entered into collaboration activities to expand their portfolio and boost their presence across countries in hyaluronic acid products market.

Protein Expression Technology Market to Expand with Significant CAGR During 2017-2027

Protein expression alludes to the technique in which proteins are incorporated, adjusted and managed in living organisms. The innovation associated with the procedure incorporates utilization of expression vectors, reagents and competent cells. A research report by Future Market Insights gives an in-depth analysis of the various protein expression technologies in its new publication titled “Protein Expression Technology Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. It includes the market forecast for the revenue share and CAGR during the projected period i.e. 2017 to 2027.

According to this extensive research, the global protein expression market is expected to grow at a robust CAGR of 7.7% and reach a market size of more than US$ 3 Bn by the end of 2027 from a value of around US$ 1,700 Mn in 2017. The estimates are based on a systematic primary and secondary research, considering the major drivers, restraints that are limiting the market and also the trends following the global protein expression technology market.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1540 

Global Protein Expression Technology Market: Dynamics

The growth of global protein technology market is contributed mostly by the advancements in technology. It is also accompanied by many other factors that are helping in the expansion of market. The major drivers are enhanced sales network and distribution channels, increasing demand in proteomics and biologics and growing demand for therapeutic antibody research. However, there are also a few factors that are limiting the growth of global protein expression technology market like in-house development of expression systems, high cost associated with expression vectors and other reagents, complex workflow and also low protein production which has the maximum restraining force.

Global Protein Expression Technology Market: Segmental Highlights

The global protein expression technology market is segmented on the basis of expression system, product type, application, end user and region.

• Among these major segment types, expression system segment is expected to have the maximum impact on the market with mammalian expression system being the most dominant segment which marks a revenue of over US$ 630 Mn and is anticipated to reach a value of around US$ 1.6 Bn by the end of 2027
• The region segment is dominated by North America region in terms of value, with a CAGR of 8.5% throughout the period of forecast. The protein expression technology market in APEJ region is projected to grow at the highest pace to register a CAGR of 8.7% and reaching a revenue of about US$ 600 Mn by 2027 end
• The product type segment is dominated by Reagents, growing at a CAGR of over 8% during the forecast period. It is followed by expression vectors which is anticipated to reach a CAGR of over 7% during 2017-2027
• End user segment is another important segment type which includes pharmaceutical companies as its dominant segment. This segment is expected to mark a revenue value of US$ 710 Mn in 2017
• By application, protein therapeutics segment is expected to be highly lucrative. It is the leading segment in terms of both value share and growth rate. By the end of the forecast period, this segment is estimated to reach a value of more than US$ 1.5 Bn with a high 8.4% CAGR during the forecast period

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1540 

Global Protein Expression Technology Market: Competitive Landscape

This comprehensive research report has included profiles of major players involved in protein synthesis technologies. Major companies such as Lonza AG, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, QIAGEN N.V., Takara Bio, Inc., Fujifilm Diosynth Biotechnologies USA, Genscript Biotech Corporation, Promega Corporation, Hudson Robotics, Inc., New England Biolabs, Inc., Merck Millipore, GeneCopoeia, Inc., Bioneer Corporation and Oxford Expression Technologies Ltd.

Anti-microbial/Anti-fungal Tests Market to Surpass US$ 1.2 billion by 2027

Microbial and fungal infections are a major cause of death globally and can even cause potential epidemics, creating a huge economic burden on countries, especially developing ones. To nip the spread of such infections in the bud, prevention is a far better solution than cure – accomplished by isolating infected cases and carrying out primary screening tests. Future Market Insights in its report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027’ has comprehensively analysed the global anti-microbial/ anti-fungal tests market for a decade. The anti-microbial/ anti-fungal tests market is expected to witness a robust CAGR of 6% from 2017 to 2027.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5566 

Region – Robust Healthcare Infrastructure in North America Enables Rapid Anti-Microbial/ Anti-Fungal Testing

North America has the largest regional contribution and is predicted to account for approx. a third of the anti-microbial/ anti-fungal tests market at the end of the forecast period. The North America anti-microbial/ anti-fungal tests market should cross a billion dollars by 2027 – the only region to do so. Most physicians on the continent typically prescribe diagnostics tests before starting any sort of treatment, fuelling demand for anti-microbial/ anti-fungal test kits. Furthermore, there is immense awareness of the side-effects of certain drugs and patients often prefer to get completely diagnosed before seeking treatment.

Test Type – Molecular Based Tests Critical in Anti-Microbial/ Anti-Fungal Tests Market

Molecular based tests dominated the global anti-microbial/ anti-fungal tests market by test type in 2017 and are likely to retain this commanding position for the foreseeable future. Molecular based tests have a market attractiveness index of 2.6 – considerably higher than all other test types in the anti-microbial/ anti-fungal tests market. Within the molecular based tests segment, companies would be advised to focus their attention on the PCR Test sub-segment as it is roughly thrice the size of DNA microarray tests in terms of value. The PCR test segment is further poised to record a CAGR of 6.4% for the decadal study.

Infection Type – Target Antimicrobial Resistance and Microbial Infection Segments in Anti-Microbial/ Anti-Fungal Tests Market

The antimicrobial and microbial resistance segments are the ones to look out for as they comprise almost 3/4th of the global anti-microbial/ anti-fungal tests market between them. The multi-drug-resistant mycobacterium tuberculosis sub-segment is the largest in the antimicrobial resistance segment and should grow at a high rate as well. Along with multi-drug-resistant mycobacterium tuberculosis, the microbial infection segment holds great potential in the anti-microbial/ anti-fungal tests market as it is on track to push past a value of US$ 1 billion by end 2027.

End User – Hospitals and Reference Labs Demand Antimicrobial/ Antifungal Testing Kits

Hospitals and reference labs are the largest end users in the anti-microbial/ anti-fungal tests market by a substantial margin. It has been observed that the global per-capita healthcare spending has doubled because of rising awareness of myriad treatment options and diagnostic tools for detecting and curing various diseases. Reference labs are predicted to grow faster than hospitals in the anti-microbial/ anti-fungal tests market.

Competition Dashboard in the Anti-Microbial/ Anti-Fungal Tests Market

The companies profiled in the report are Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Bruker Corporation, Danaher Corporation, Erba Mannheim, F. Hoffmann-La Roche AG, Luminex Corporation, Meridian Bioscience, Norgen Biotek Corp., Omega Diagnostics Group Plc., Qiagen N.V., Quidel Corporation, and Thermo Fisher Scientific Inc.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5566 

Takeaways

The prevalence and incidence rate of infectious diseases such as diarrhoea and malaria is at an all-time high in Asia and Africa. Governmental and non-governmental organizations such as the WHO are seeking to reduce prevalence rates by early diagnosis through antimicrobial and antifungal kits. In addition to this, government tenders and partnerships with manufacturers is anticipated to provide a steady revenue stream for the latter, growing the  anti-microbial/ anti-fungal tests market as a whole.

Hips & Knees Reconstructive Market to Reflect Significant Growth Pace by 2027

Future Market Insights (FMI) delivers key insights on the global hips & knees reconstructive market in its upcoming report titled “Hips & Knees Reconstructive Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017 – 2027)”. In terms of revenue, the global hips & knees reconstructive market is projected to register a CAGR of 6.4% over the forecast period, owing to various factors regarding which FMI offers detailed insights and information in this report. A key trend witnessed in the global hips & knees reconstructive market is that manufacturers are focussing on new product innovations that are driving technological advancements, but are also cost effective. Globally, surgeons are adopting new minimally invasive surgical procedures, computer-navigated and robot-assisted surgical procedures, 3D printing technology and smart implants, which will have a significant impact on the overall growth of the global hips & knees reconstructive market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2717 

Global Hips & Knees Reconstructive Market: Segmental Forecast

The global hips & knees reconstructive market is segmented based on product type, fixation type, end user and region. Based on product type, the market segmented into hip and knee reconstruction. The fixation type is segmented into cement, cementless and hybrid fixations. Total hip and knee reconstruction is the leading product type segment in the global hips & knees reconstructive market over the forecast period. The knee reconstruction segment is estimated to be valued at US$ 8,719.9 Mn by 2017 end and is projected to be valued at US$ 16,653.2 Mn by 2027 end, growing at a CAGR of 6.8% during the forecast period. The hip reconstruction segment is expected to be the second most lucrative segment in the global hips & knees reconstructive market, with an attractiveness index of 0.8 during the forecast period.

Based on fixation type, cementless fixation is the leading segment in the global hips & knees reconstructive market over the forecast period. The hybrid segment accounted for 28.1% value share in 2016 and is projected to account for 29.9% share by 2027 end. It is the second most attractive segment in the global hips & knees reconstructive market with an attractiveness index of 1.0 during the forecast period.

By end user, the market is segmented into hospitals, orthopaedic clinics, and ambulatory surgical centres. Hospitals is the leading segment in the global hips & knees reconstructive market over the forecast period. Demand for hip and knee reconstruction is expected to be the highest in hospitals, and this segment is projected to register a CAGR of 6.1 % over the forecast period.

Global Hips & Knees Reconstructive Market: Regional Forecast

North America is expected to gain popularity over the forecast period, driven by an increasing geriatric population requiring hip and knee reconstruction. The North America market is predicted to dominate the global hips & knees reconstructive market, accounting for a maximum revenue share of the market by 2017 end. The North America, Western Europe, and Asia Pacific excluding Japan markets are collectively expected to account for around 79% of the global hips & knees reconstructive market value share by 2017 end. Revenue from the market in APEJ is estimated to expand at a CAGR of 6.8% over the forecast period.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2717 

Key Players

Some of the key hips & knees reconstructive market players covered in the report include Zimmer Biomet, Stryker, DePuy Companies (Sub. Johnson & Johnson Services, Inc.), Smith & Nephew Plc, Exactech, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Limacorporate S.p.A., CeramTec, and ConforMIS. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Non-Surgical Fat Reduction Market Rugged Expansion Foreseen by 2022

Unhealthy gain in weight is a rising epidemic observed across the globe. This is mainly caused owing to improper eating habits, wrong time of eating, less or no exercise, health ignorance owing to increased reliance on medications, etc. However, along with this rising epidemic, there is an increase in the awareness among people to look healthy and slim. This has triggered the emergence of techniques and procedures for fat loss. The advent of technology has given rise and popularity to non-invasive or non-surgical procedures for fat removal. Under proper medication, care and guidance, these non-surgical procedures deliver high benefits in terms of efficiency, quick results and convenience. These aspects along with less procedure time and less complications are driving the growth of the global non-surgical fat reduction market. However, higher costs associated with this technique coupled with hidden procedural costs pose a challenge to the growth of the global market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5321 

The comprehensive research study on “Non-Surgical Fat Reduction Market: Global Industry Analysis (2012-2016) and opportunity Assessment (2017-2022)” skilfully analysed and crafted by Future Market Insights delivers the much needed value addition to the reader with the help of which expansion strategies can be devised to obtain competitive advantage. According to this study, the global non-surgical fat reduction market is projected to grow at significant CAGR of 5.1% throughout the assessment period, 2017-2022.

3 Key Projections on Global Non-Surgical Fat Reduction Market

• By Product type, the laser based devices segment is expected to be the largest segment in terms of value and market share. Moreover, this segment is projected to grow at the highest pace to register a CAGR of 5.6% throughout the period of assessment
• By End user type, the beauty clinics segment is expected to show high demand for non-surgical fat reduction treatments. This segment is expected to comparatively grow at a high rate during the 2017-2022 period. The dermatology clinics segment shows a high adoption of non-surgical fat reduction procedures. This segment is likely to dominate the global market in the years to come
• By Region, North America is expected to be highly attractive for the growth of the global non-surgical fat reduction market. This region is highly lucrative for the market growth owing to high technology advancements, high disposable income of people and increasing number of key players dealing with non-surgical fat reduction devices in this region

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5321 

Competitive Scenario in the Global Non-Surgical Fat Reduction Market

The non-surgical fat reduction market research study includes a detailed profiling of key players operating in this market. Company overview, key financials, SWOT analysis and developments and key innovations of the tier players is studied during the course of the research and depicted in this study. Tier players like Cutera Inc., Lutronic Corporation, Syneron Medical Ltd., Cynosure, Inc., Fotona d.d., Solta Medical Inc., Venus Concept Canada Corp., Lynton Lasers Ltd., Alma Lasers, Ltd., EL.En. S.p.A., and Sciton, Inc., are profiled in this research.

Pigmented Lesion Treatment Market Expected to Increase at a CAGR 6.5% through 2017 to 2022

A new report published by Future Market Insights (FMI) projects that the global pigmented lesion treatment market will witness an above-average CAGR between 2017 and 2022 to reach a valuation of US$ 375 Mn. In the past couple of years, demand for pigment lesion treatment has increased to a significant extent. Pigmented lesion is a skin disease or condition that is becoming increasingly popular across the globe. The condition is more prevalent in the elderly population as aging is one of its prominent causes. A patient suffering for pigmented lesion will develop marks on the skin, primarily on facial skin. In some cases, a person can develop the condition due to extreme sun exposure. Other causes of pigmented lesion include endogenous and exogenous aetiologies. Presently, there is a wide range of treatment available for pigmented lesion. These novel treatments are quite effective and affordable.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5322 

Companies are focusing on development of advanced treatment modules that are cost-effective and deliver superior results. Many of the companies are launching novel non-invasive med-aesthetic systems that are capable of effectively treating severe impacts of pigmented lesions. Due to their effectiveness and comfort, these innovative treatments are rapidly gaining patient trust. Moreover, the latest pigmented lesion treatment devices ensure patient safety as well as do not cause any adverse side effects. Extensive use of synthetic makeup, smoking and consumption of intoxicants can also influence the development of pigmented lesion. Pigmentation, mottled, dyschromia, telangiectasia, melisma, solar lentigo, rosacea, broken capillaries, poikilormera, and erythema are some of prominent types of pigmented lesions. Such conditions may also arise due to various natural or environmental causes such as genetic makeup, aging phenomena and photodamage. In some rear events, a person may also develop pigmented lesion as a side effect of any other medical procedure he or she undergoing. Development, freckles, pigment-related marks, age spots, hyperpigmentation, pigmented nevi and actinic keratosis are some of the characteristics of pigmented lesion.

Key Insights from Global Pigmented Lesion Treatment Market Include:

• Pigmented lesion treatment market is North America market will retain its dominant position throughout the forecast period. The region is anticipated to account for a significant revenue share of the global market in 2017 and beyond. In addition, the region’s market is projected to soar at an impressive CAGR between 2017 and 2022.
• Presence of top market participants coupled with widespread consumer awareness about the availability of advanced treatment modules is supplementing the growth of the market in the region. Furthermore, the desire to look attractive and young among consumers who have passed their youth is likely to influence the demand for pigmented lesion treatment in the forthcoming years.
• Based on products, demand for IPL devices is expected to remain significantly high in 2017 and beyond. Global sales of IPPL devices is anticipated to command for more than 50% revenue share of the market.
• Over US$ 190 Mn worth IPL devices are estimated to be shipped globally by 2022-end. Meanwhile, energy bases devices are expected hold the second spot throughout the assessment period.
• Dermatology clinics will remain the largest end users of pigmented lesion treatment devices during the forecast period (2017-2022).

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5322 

Competition Tracking

Fotona d.d., Alma Lasers, Ltd., EL.En. S.p.A., Solta Medical Inc., Cynosure, Inc., Syneron Medical Ltd., Cutera Inc., Sciton, Inc., Lynton Lasers Ltd, Lumenis Ltd., Strata Skin Sciences, Inc., and Lutronic Corporation are some of the leading companies operating in the global market for pigmented lesion treatment.